🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to compare patient medication satisf...
Status
Completed
Location
Teva Investigational Site 13485
Start Date
2015-08-10
Trial ID
NCT02499900
Treatments Being Tested
Traditional Magnetic Resonance Imaging (MRI) in Multiple Sclerosis (MS) has...
Status
Completed
Location
MS Clinical Trials Group - UBC
Start Date
2016-10
Trial ID
NCT02869360
This open-label extension study will evaluate the long-term safety of glati...
Status
Completed
Location
Teva Investigational Site 009
Start Date
1994-03-26
Trial ID
NCT00203021
Treatments Being Tested
FDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) tar...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2018-05-02
Trial ID
NCT03500328
Treatments Being Tested
Teva is developing 40 mg/ml Glatiramer Acetate (GA) Injection , administere...
Status
Completed
Location
Teva Benelux
Start Date
2006-07-27
Trial ID
NCT00326625
Treatments Being Tested
This is an open-label, randomized, multi-center, parallel-arm study to asse...
Status
Completed
Location
Teva Investigational Site 10706
Start Date
2013-06
Trial ID
NCT01874145
Treatments Being Tested
The investigator believes that injecting Copaxone into tumors will help par...
Status
Unknown
Location
University of Kansas Cancer Center - CRC
Start Date
2019-07-26
Trial ID
NCT03982212
Treatments Being Tested
Teva is developing a 40 mg/ml GA Injection, administered once daily under t...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00337779
Treatments Being Tested
This is a Phase 2, randomized, rater-blinded, 5-arm, parallel-group trial t...
Status
Terminated
Location
Research site
Start Date
2013-10
Trial ID
NCT01963611
The objective of the clinical study of the medicinal product for medical us...
Status
Completed
Location
Multiple Locations
Start Date
2013-10
Trial ID
NCT02753088
Treatments Being Tested